IP Library Granted Patent US 12,446,794
Granted Patent B2
US 12,446,794 · App. 18/766,498 · Granted Oct 21, 2025

Electromechanical pill device with localization capabilities

Inventors: Mitchell Lawrence Jones (La Jolla, CA); Alain Labbé (St. Philippe, CA); Mark Sasha Drlik (Victoria, CA); Christian Terry Proch McMechan (Victoria, CA)
Assignee: BT Bidco, Inc.
A61B5/065A61B1/041A61B5/002A61B5/0086A61B5/073A61B5/6861A61B5/7264H04B10/1143H04B13/00A61B5/0017A61B2560/0443A61B2560/0462A61B2562/162
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,446,794
App. No.
18/766,498
Granted
Oct 21, 2025
Kind
B2
Abstract

Various embodiments are described herein for a device, system, and method for identifying a location of an ingestible device within a gastrointestinal tract of a body. In some embodiments, the ingestible device includes a sensing unit with an axial optical sensing sub-unit located proximal to at least one end of the device, and a radial optical sensing sub-unit located proximal to a radial wall of the device, and may autonomously identify a location within the gastrointestinal tract. In some embodiments, the ingestible device includes optical illumination sources and detectors that operate at a plurality of different wavelengths, and may discern regions of a gastrointestinal tract by using the reflection properties of organ tissue and occasional particulates. In some embodiments, the ingestible device may sample fluid or release medicament based on a detected device location.

Claims (53)

1. An ingestible device, comprising:

a housing, comprising:

a chamber configured to store a therapeutic agent;

an actuator having a first state in which the therapeutic agent is stored in the chamber and

a second state in which the therapeutic agent is released from the chamber to an exterior of the housing; and

a detector configured in a first configuration to detect a first light characteristic of a GI tract of a subject and in a second configuration to detect a second light characteristic of the GI tract of the subject, the first light characteristic and the second light characteristic in a spectrum selected from the group consisting of a red spectrum, a blue spectrum and a green spectrum; and

a microcontroller configured to determine a location of the ingestible device in a GI tract of a subject based on the first light characteristic of the GI tract and the second light characteristic of a GI tract and based on the location of the ingestible device in the GI tract of the subject detected by the detector, cause the actuator to move from its first state to its second state so that the therapeutic agent is delivered to the exterior of the ingestible device.

2. The ingestible device of claim 1 , further comprising a light source configured to transmit a first wavelength of light toward an environment external to the housing.

3. The ingestible device of claim 2 , wherein the light source is configured to transmit a second wavelength of light toward an environment external to the housing, and the second wavelength is different from the first wavelength.

4. The ingestible device of claim 3 , wherein:

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum; and

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum.

5. The ingestible device of claim 2 , wherein the light source comprises a light emitting diode.

6. The ingestible device of claim 2 , wherein the light source comprises a RGB diode package.

7. The ingestible device of claim 1 , wherein the detector comprises an array of detectors.

8. The ingestible device of claim 1 , comprising one or more sensing sub-units, wherein:

the one or more sensing sub-units comprise the detector; and

the one or more sensing are configured to:

transmit a first wavelength of light towards an environment external to the housing;

for each iteration of transmitting the first wavelength of light, detect the first wavelength of light after it has reflected from the environment external to the housing;

transmit a second wavelength of light towards the environment external to the housing, the second wavelength being different from the first wavelength; and

for each iteration of transmitting the second wavelength of light, detect the second wavelength of light after it has reflected from the environment external to the housing.

9. The ingestible device of claim 8 , wherein the microprocessor is configured to:

generate a first data set comprising a plurality of first values, wherein each first value is indicative of an amount of light detected by the device at the first wavelength for a corresponding iteration detecting the first wavelength of light after it has reflected from the environment external to the housing;

generate a second data set comprising a plurality of second values, wherein each second value is indicative of an amount of light detected by the device at the second wavelength for a corresponding iteration of detecting the second wavelength of light after it has reflected from the environment external to the housing; and

determine a change in a location of the ingestible device within the GI tract of the subject by comparing the first data set to the second data set.

10. The ingestible device of claim 1 , wherein the first light characteristic and the second light characteristic are detected in both a radial direction and an axial direction with respect to housing of the ingestible device.

11. The ingestible device of claim 1 , further comprising a light source configured to transmit white light toward an environment external to the housing.

12. An ingestible device, comprising:

a housing, comprising:

a chamber;

a member having a first state in which the chamber does not allow a sample from an exterior of the housing to enter the chamber and a second state in which the member of the housing allows a sample to enter the chamber; and

a detector configured in a first configuration to detect a first light characteristic of a GI tract of a subject and in a second configuration to detect a second light characteristic of the GI tract of the subject location of the ingestible device in a GI tract of a subject, the first light characteristic and the second light characteristic in a spectrum selected from the group consisting of a red spectrum, a blue spectrum and a green spectrum; and

a microcontroller configured to determine a location of the ingestible device in a GI tract of a subject based on the first light characteristic of the GI tract and the second light characteristic of a GI tract and based on the location of the ingestible device in the GI tract of the subject detected by the detector, cause the member to move from its first state to its second state so that a sample can move from the exterior of the housing into the chamber.

13. The ingestible device of claim 12 , further comprising a light source configured to transmit a first wavelength of light toward an environment external to the housing.

14. The ingestible device of claim 13 , wherein the light source is configured to transmit a second wavelength of light toward an environment external to the housing, and the second wavelength is different from the first wavelength.

15. The ingestible device of claim 14 , wherein:

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum; and

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum.

16. The ingestible device of claim 13 , wherein the light source comprises a light emitting diode.

17. The ingestible device of claim 13 , wherein the light source comprises a RGB diode package.

18. The ingestible device of claim 12 , wherein the detector comprises an array of detectors.

19. The ingestible device of claim 12 , comprising one or more sensing sub-units, wherein:

the one or more sensing sub-units comprise the detector; and

the one or more sensing are configured to:

transmit a first wavelength of light towards an environment external to the housing;

for each iteration of transmitting the first wavelength of light, detect the first wavelength of light after it has reflected from the environment external to the housing;

transmit a second wavelength of light towards the environment external to the housing, the second wavelength being different from the first wavelength; and

for each iteration of transmitting the second wavelength of light, detect the second wavelength of light after it has reflected from the environment external to the housing.

20. The ingestible device of claim 19 , wherein the microprocessor is configured to:

generate a first data set comprising a plurality of first values, wherein each first value is indicative of an amount of light detected by the device at the first wavelength for a corresponding iteration detecting the first wavelength of light after it has reflected from the environment external to the housing;

generate a second data set comprising a plurality of second values, wherein each second value is indicative of an amount of light detected by the device at the second wavelength for a corresponding iteration of detecting the second wavelength of light after it has reflected from the environment external to the housing; and

determine a change in a location of the ingestible device within the GI tract of the subject by comparing the first data set to the second data set.

Assignments (3)
SECURITY INTEREST Recorded Aug 15, 2025
From: BT BIDCO, INC.
To: GLAS USA LLC
Reel/Frame 072473/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO, INC.
Reel/Frame 070585/0061 →
LIEN Recorded Mar 18, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO LLC
Reel/Frame 070552/0366 →
Continuity (4)
Continuation 17030533 · Sep 24, 2020
Continuation 15514413
Provisional Application 62055244 · Sep 25, 2014
Related Publication 20240358273A1 · Oct 31, 2024
References Cited (187)
US 3057344A · Alberto · 1962 [cited by applicant]
US 3118439A · Barana · 1964 [cited by applicant]
US 3315660A · Abella · 1967 [cited by applicant]
US 3485235A · Felson · 1969 [cited by applicant]
US 4223680A · Jobsis · 1980 [cited by applicant]
US 4239040A · Hosova · 1980 [cited by applicant]
US 4292961A · Kawashima · 1981 [cited by applicant]
US 4425117A · Hugeman · 1984 [cited by applicant]
US 4507115A · Kambara · 1985 [cited by applicant]
US 4522625A · Edgren · 1985 [cited by applicant]
US 4573447A · Thrash et al. · 1986 [cited by applicant]
US 4844076A · Lesho · 1989 [cited by applicant]
US 5170801A · Casper · 1992 [cited by applicant]
US 5279607A · Schentag · 1994 [cited by applicant]
US 5395366A · Andrea · 1995 [cited by applicant]
US 5604531A · Iddan et al. · 1997 [cited by applicant]
US 5858001A · Tsals · 1999 [cited by applicant]
US 5951538A · Joshi · 1999 [cited by applicant]
US 5984860A · Shan · 1999 [cited by applicant]
US 6082366A · Andra et al. · 2000 [cited by applicant]
US 6344027B1 · Goll · 2002 [cited by applicant]
US 6428469B1 · Iddan et al. · 2002 [cited by applicant]
US 6576429B1 · Hallgren · 2003 [cited by applicant]
US 6632216B2 · Houzego · 2003 [cited by applicant]
US 7056673B2 · Kamme et al. · 2006 [cited by applicant]
US 7553276B2 · Iddan · 2009 [cited by applicant]
US 7611480B2 · Levy · 2009 [cited by applicant]
US 7797033B2 · D'Andrea et al. · 2010 [cited by applicant]
US 8185185B2 · Gilreath · 2012 [cited by applicant]
US 8206285B2 · Blijevsky · 2012 [cited by applicant]
US 8394034B2 · Iddan · 2013 [cited by applicant]
US 8540623B2 · Blijevsky · 2013 [cited by applicant]
US 8626268B2 · Adler · 2014 [cited by applicant]
US 8696602B2 · Semler et al. · 2014 [cited by applicant]
US 8911368B2 · Rabinovitz et al. · 2014 [cited by applicant]
US 9026192B2 · Blit et al. · 2015 [cited by applicant]
US 9131842B2 · Old · 2015 [cited by applicant]
US 9324145B1 · Cherevatsky · 2016 [cited by applicant]
US 10588608B2 · Jones et al. · 2020 [cited by applicant]
US 10835152B2 · Jones et al. · 2020 [cited by applicant]
US 20010035902A1 · Iddan et al. · 2001 [cited by applicant]
US 20010051766A1 · Gazdzinski et al. · 2001 [cited by applicant]
US 20020099310A1 · Kimchy et al. · 2002 [cited by applicant]
US 20020198470A1 · Imran et al. · 2002 [cited by applicant]
US 20030139661A1 · Kimchy · 2003 [cited by applicant]
US 20030191430A1 · Andrea et al. · 2003 [cited by applicant]
US 20030208107A1 · Refael et al. · 2003 [cited by applicant]
US 20040253304A1 · Gross et al. · 2004 [cited by applicant]
US 20040254455A1 · Iddan · 2004 [cited by applicant]
US 20050010168A1 · Kendall · 2005 [cited by applicant]
US 20050049462A1 · Kanazawa · 2005 [cited by applicant]
US 20050065441A1 · Glukhovsky · 2005 [cited by applicant]
US 20050158246A1 · Takizawa · 2005 [cited by applicant]
US 20050266074A1 · Zilberstein et al. · 2005 [cited by applicant]
US 20060069317A1 · Horn et al. · 2006 [cited by applicant]
US 20060178537A1 · Mintchev · 2006 [cited by applicant]
US 20070027362A1 · Handa · 2007 [cited by applicant]
US 20070043320A1 · Kenany · 2007 [cited by applicant]
US 20070092401A1 · Liao et al. · 2007 [cited by applicant]
US 20070161928A1 · Sprenkels · 2007 [cited by applicant]
US 20070293736A1 · Casset · 2007 [cited by applicant]
US 20080027329A1 · Ghdchovsky · 2008 [cited by applicant]
US 20080051633A1 · Blijevsky · 2008 [cited by applicant]
US 20080194912A1 · Trovato · 2008 [cited by applicant]
US 20080208077A1 · Iddan et al. · 2008 [cited by applicant]
US 20080234548A1 · Amit · 2008 [cited by applicant]
US 20080294023A1 · Rabinovitz et al. · 2008 [cited by applicant]
US 20090131784A1 · Betesh · 2009 [cited by applicant]
US 20090306633A1 · Trovato et al. · 2009 [cited by applicant]
US 20100045786A1 · Kitamura · 2010 [cited by applicant]
US 20100111763A1 · Kahn et al. · 2010 [cited by applicant]
US 20100249645A1 · Semler et al. · 2010 [cited by applicant]
US 20100285475A1 · Palanisanny · 2010 [cited by applicant]
US 20110046458A1 · Pinedo · 2011 [cited by applicant]
US 20110125007A1 · Steinberg · 2011 [cited by applicant]
US 20110125031A1 · Blit et al. · 2011 [cited by applicant]
US 20110306055A1 · Haince · 2011 [cited by applicant]
US 20110313348A1 · Potter et al. · 2011 [cited by applicant]
US 20120041465A1 · Shalon · 2012 [cited by applicant]
US 20120136209A1 · Kostenich et al. · 2012 [cited by applicant]
US 20120258473A1 · Moriya et al. · 2012 [cited by applicant]
US 20130013031A1 · Ben-Yehuda et al. · 2013 [cited by applicant]
US 20130018279A1 · Plante et al. · 2013 [cited by applicant]
US 20130022983A1 · Grifantini · 2013 [cited by applicant]
US 20130085414A1 · Yamatani · 2013 [cited by applicant]
US 20130158344A1 · Taniguchi · 2013 [cited by applicant]
US 20140113313A1 · Moreau · 2014 [cited by applicant]
US 20140128833A1 · Vogt · 2014 [cited by applicant]
US 20140183362A1 · Islam · 2014 [cited by examiner]
US 20140206956A1 · Rabinovitz et al. · 2014 [cited by applicant]
US 20140296666A1 · Rabinovitz et al. · 2014 [cited by applicant]
US 20140343451A1 · Pannell · 2014 [cited by applicant]
US 20150011874A1 · Amoako-Tuffour et al. · 2015 [cited by applicant]
US 20150057548A1 · Kaufman · 2015 [cited by applicant]
US 20160033373A1 · Hill et al. · 2016 [cited by applicant]
US 20160038086A1 · Wrigglesworth · 2016 [cited by applicant]
US 20160066855A1 · Hyde · 2016 [cited by applicant]
US 20160114142A1 · Ziale et al. · 2016 [cited by applicant]
US 20160213234A1 · Poon · 2016 [cited by applicant]
US 20160249793A1 · Wang · 2016 [cited by applicant]
US 20170006202A1 · Otani · 2017 [cited by applicant]
US 20170106099A1 · Bellinger et al. · 2017 [cited by applicant]
US 20170246438A1 · Aran et al. · 2017 [cited by applicant]
US 20170258583A1 · McCawley · 2017 [cited by applicant]
US 20170296092A1 · Jones et al. · 2017 [cited by applicant]
US 20180049725A1 · Jones et al. · 2018 [cited by applicant]
US 20180052084A1 · Jones et al. · 2018 [cited by applicant]
US 20180070857A1 · Jones et al. · 2018 [cited by applicant]
US 20180160950A1 · Rabinovitz et al. · 2018 [cited by applicant]
US 20180279908A1 · Jones et al. · 2018 [cited by applicant]
US 20200245897A1 · Jones et al. · 2020 [cited by applicant]
CN 1856290 · 2006 [cited by applicant]
CN 101495164 · 2009 [cited by applicant]
CN 103209632 · 2013 [cited by applicant]
EP 108607 · 1983 [cited by applicant]
EP 1243524 · 2002 [cited by applicant]
EP 1530950 · 2005 [cited by applicant]
EP 1932462 · 2008 [cited by applicant]
EP 2057934 · 2009 [cited by applicant]
EP 3108810 · 2016 [cited by applicant]
JP 2005073888 · 2005 [cited by applicant]
JP 2013500815 · 2013 [cited by applicant]
JP 2015509744 · 2015 [cited by applicant]
KR 1020080033677A · 2008 [cited by applicant]
KR 1020080043923A · 2008 [cited by applicant]
KR 100931946 · 2009 [cited by applicant]
KR 1020110034265A · 2011 [cited by applicant]
RU 2269343 · 2006 [cited by applicant]
WO WO2001045552 · 2001 [cited by applicant]
WO WO2010091926 · 2010 [cited by applicant]
WO WO2010146588 · 2010 [cited by applicant]
WO WO2011016002 · 2011 [cited by applicant]
WO 2011037299A1 · 2011 [cited by applicant]
WO WO2013088444 · 2013 [cited by applicant]
WO WO2013120184 · 2013 [cited by applicant]
WO WO2015059569 · 2015 [cited by applicant]
WO WO2015099749 · 2015 [cited by applicant]
WO WO2015147305 · 2015 [cited by applicant]
WO WO2016054015 · 2016 [cited by applicant]
WO WO2017004000 · 2017 [cited by applicant]
WO WO2016049602 · 2018 [cited by applicant]
WO WO2018050647 · 2018 [cited by applicant]
Anselmo et al., “Non-invasive delivery strategies for biologics”, Nature Reviews, Drug Discovery, vol. 18, 19-40, 2019. [cited by applicant]
Aran et al., “An oral microjet vaccination system elicits antibody production in rabbits”, Sci. Transl. Med. 9, eaaf6413,10 pages, 2017. [cited by applicant]
Australian Office Action in Application No. 2015319850, dated Aug. 2, 2019, 4 pages. [cited by applicant]
Bao and Pahlavan, “Motion estimation of the endoscopy capsule using region-based kernel SVM classifier.” 2013 IEEE International. Conf. Electro-Information Technol., EIT 2013, 5 pages. [cited by applicant]
Barolet et al., “Current trends in needle-free jet injection: an update”, Clinical, Cosmetic and Investigational Dermatology, 11, 231-238, 2018. [cited by applicant]
Battula et al., “A Miniature Shock Wave Driven Micro-Jet Injector for Needle-Free Vaccine/Drug Delivery”, Biotechnology and Bioengineering, vol. 113, No. 11, 2507-2512, 2016. [cited by applicant]
Chen et al., “Developing assessment system for wireless capsule endoscopy videos based on event detection”, Proceedings of SPIE, vol. 7260, p. 72601G, 2009. [cited by applicant]
Chinese Office Action in Application No. 2015800635638, dated Sep. 29, 2019, 10 pages. [cited by applicant]
Dingle et al., “Stable and Noncompetitive RNA Internal Control for Routine Clinical Diagnostic Reverse Transcription-PCR”, Journal of Clinical Microbiology, vol. 42(3): 1003-1011, Mar. 2004. [cited by applicant]
Eurasian Office Action in Application No. 201790706/31, dated May 29, 2019, 4 pages, (with English Translation). [cited by applicant]
European Exam Report in Application No. 157759119.9, dated Jan. 2, 2020, 4 pages. [cited by applicant]
European Exam Report in Application No. 157759119.9, dated Mar. 11, 2019, 4 pages. [cited by applicant]
European Exam Report in Application No. 157759119.9, dated May 28, 2018, 3 pages. [cited by applicant]
Hunter et al., “Aerosol delivery of Virus-like Particles to the genital tract induces local and systemic antibody responses”, Vaccine, 29(28): 4584-4592, 2011. [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2015/052500, dated Dec. 17, 2015, 15 pages. [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2017/050642, dated Jan. 29, 2018, 28 pages. [cited by applicant]
International Search Report and Written Opinion in International Application No. PCT/US2018/025191, dated Oct. 19, 2018. [cited by applicant]
International Search Report Written Opinion. International Application No. PCT/US2017/047476, dated Jan. 22, 2018, 20 pages. [cited by applicant]
International Search Report Written Opinion. International Application No. PCT/US2017/047481, dated Jan. 17, 2018, 18 pages. [cited by applicant]
Invitation to Pay Additional Fees and Where Applicable Protest Fee International Application No. PCT/US2012/047476, dated Nov. 13, 2017, 13 pages. [cited by applicant]
Invitation to Pay Additional Fees and Where Applicable Protest Fee International Application No. PCT/US2017/050642, dated Dec. 8, 2017, 25 pages. [cited by applicant]
Invitation to Pay Additional Fees for International Application No. PCT/US2017/047481, dated Nov. 24, 2017, 14 pages. [cited by applicant]
Invitation to Pay Fees om International Application No. PCT/US2018/025191, Jul. 12, 2018, 22 pages. [cited by applicant]
Iverson et al., “An innate antiviral pathway acting before interferons at epithelial surfaces”, Nature Immunology, vol. 17, No. 2, 150-158, 2016. [cited by applicant]
Jacques, “Optical properties of biological tissues: a review,” Phys., Med. Biol., IPEM, 58, R37, 28 pages, 2013. [cited by applicant]
Japanese Office Action in Application No. 2017-516962, dated Jul. 22, 2019, 4 pages. [cited by applicant]
Kale et al., “Needle free injection technology—An overview”, Innovations in pharmacy, vol. 1, No. 1, Article 148, 10 pages, 2014. [cited by applicant]
Kane et al., “Fecal Lactoferrin Is a Sensitive and Specific Marker in Identifying Intestinal Inflammation”, The American Journal of Gastroenterology, 98(6): 1309-1314, 2003. [cited by applicant]
Kostic et al., “The Gut Microbiome and Disease”, Gastroenterology, vol. 146(6): 1489-1499, 2014. [cited by applicant]
Lambert et al., “Autonomous telemetric capsule to explore the small bowel,” Med Biol Eng Comput 29(2): 191-196, 1991. [cited by applicant]
Lee et al.. “Automatic Classification of Digestive Organs in Wireless Capsule Endoscopy Videos”, Applied Computing, pp. 1041-1045, 2007. [cited by applicant]
Lehmann et al.,“The role and utility of faecal markers in inflammatory bowel disease”, Therapeutic Advances in Gastroenterology, vol. 8(1): 23-36, 2015. [cited by applicant]
Li et al., “Outlier detection and removal improves accuracy of machine learning approach to multispectral burn diagnostic imaging,” J. Biomed. Opt., 2015, 20:121305. [cited by applicant]
Lo et al., “The use of carbon dioxide in gastrointestinal endoscopy”, Gastrointestinal Endoscopy, vol. 83, No. 5, 857-865, 2016. [cited by applicant]
Sanschagrin and Yergeau, Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons, Journal of Visualized Exoeriments, Issue 90: 51709, Aug. 2014. [cited by applicant]
Sartor and Mazmanian, “Intestinal Microbes in Inflammatory Bowel Diseases”, The American Journal of Gastroenterology Suoolements, vol. 1, 12-21, 2012. [cited by applicant]
US Final Office Action in U.S. Appl. No. 15/680,400, dated Jan. 15, 2020, 14 pages. [cited by applicant]
US Non-Final Office Action in U.S. Appl. No. 15/514,413, dated Mar. 20, 2020, 12 pages. [cited by applicant]
US Non-Final Office Action in U.S. Appl. No. 15/680,400, dated Mar. 5, 2020, 18 pages. [cited by applicant]
US Non-Final Office Action in U.S. Appl. No. 15/680,400, dated Oct. 1, 2019, 11 pages. [cited by applicant]
US Non-Final Office Action in U.S. Appl. No. 15/940,407, dated Jun. 15, 2020, 17 pages. [cited by applicant]
Wright et al., “Recent Advances in Characterizing the Gastrointestinal Microbiome in Crohn's Disease: A Systematic Review”, Inflammatory Bowel Disease Journal, vol. 21(6): 1219-1228, 2015. [cited by applicant]
US Non-Final Office Action in U.S. Appl. No. 15/940,407, dated Apr. 7, 2021, 31 pages. [cited by applicant]
EP Extended European Search Report in European Appln. No. 20207295.5, dated Feb. 23, 2021, 7 pages. [cited by applicant]
IL Office Action in Israel Appln. No. 251363, dated Jun. 12, 2020, 6 pages (with English translation). [cited by applicant]